Zytronic’s FY20 results were well flagged within October’s trading update with revenue (£12.7m) and cash (£14.0m) already declared. Whilst no material improvement is expected during H1’21, there has recently been some increase in enquiries and activity levels. Encouragingly, following a realignment of the cost base, the EBITDA run rate is positive. The Board is again looking at options for the distribution of surplus cash and the current rating is very modest indeed based on pre-COVID levels of ....
